Caffeine Citrate Oral Solution NDC 72485-110

NDC codes

FDA NDC Directory

Product NDC (as listed)72485-110Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72485-0110Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72485-110-10	72485011010	10 VIAL, SINGLE-DOSE in 1 BOX (72485-110-10) / 3 mL in 1 VIAL, SINGLE-DOSEMarketed from Mar 1, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Caffeine Citrate Oral Solution
Generic name (nonproprietary): caffeine citrate
Active ingredients: Caffeine citrate — 60 mg/3mL
Dosage form: Solution
Route: Oral
Labeler: Armas Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213202
Marketing start: Mar 1, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)Xanthines (Chemical structure)
Identifiers: Product ID 72485-110_492b9f6d-ad36-4fd7-a3d5-b6cb4a8f01ccSPL ID 492b9f6d-ad36-4fd7-a3d5-b6cb4a8f01ccSPL set ID 2bd238d4-4657-4341-9c28-1b468b8f3bf8RxCUI 849928UNII U26EO4675QUPC 0372485110100
Pharmacologic class: Central Nervous System Stimulant; Methylxanthine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472485011010 followed by a unit qualifier and the quantity

Package 72485-0110-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 31, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Caffeine citrate is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213202

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213202
Product	Strength	Form · route	Labeler	Product NDC
Caffeine Citrate	Caffeine citrate 60 mg/3mL	SolutionOral	Micro Labs Limited	42571-346

Caffeine Citrate Oral Solution (caffeine citrate) NDC 72485-110